Comprehensive Visual Rating Scale on Magnetic Resonance Imaging: Application to Prodromal Alzheimer Disease

Overview

Journal Ann Geriatr Med Res

Specialty Geriatrics

Date 2021 Mar 15

PMID 33715339

Citations 1

Authors

Jae Kyung Chung

Jae-Won Jang

Affiliations

Soon will be listed here.

Abstract

Background: A comprehensive visual rating scale (CVRS) using brain magnetic resonance imaging (MRI) was previously developed to evaluate structural changes in the brains of older patients. This study investigated the usefulness of the CVRS in predicting dementia with Alzheimer disease (AD) in patients with prodromal AD.

Methods: We included 189 patients with prodromal AD with available data from the Alzheimer's Disease Neuroimaging Initiative study. We evaluated all patients using CVRS and assessed their progression to AD dementia over 3 years of longitudinal follow-up. Survival analysis was performed using the Cox proportional hazards model to analyze the hazard ratios of the CVRS for progression to AD dementia.

Results: Among 189 patients with prodromal AD, 61 (32.3%) progressed to dementia. The mean baseline CVRS scores differed significantly between the stable and progressive groups (9.9±5.1 vs. 12.4±4.9; p=0.002). An initial high CVRS score was an independent risk factor for the progression to AD dementia (hazard ratio=1.110; 95% confidence interval, 1.043-1.182).

Conclusion: The baseline CVRS score predicted the progression to dementia in patients with prodromal AD, indicating its independent association with longitudinal cognitive decline.

Citing Articles

Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy.

Jeong W, Min J, Kang T, Bae H PLoS One. 2023; 18(6):e0286727.

PMID: 37289754 PMC: 10249790. DOI: 10.1371/journal.pone.0286727.

References

Kim G, Kim J, Choi K, Lim S, Lee J, Na D . T1-weighted axial visual rating scale for an assessment of medial temporal atrophy in Alzheimer's disease. J Alzheimers Dis. 2014; 41(1):169-78. DOI: 10.3233/JAD-132333. View

Rafii M, Aisen P . Alzheimer's Disease Clinical Trials: Moving Toward Successful Prevention. CNS Drugs. 2018; 33(2):99-106. PMC: 6367028. DOI: 10.1007/s40263-018-0598-1. View

Jang J, Park S, Park Y, Baek M, Lim J, Youn Y . A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition. J Alzheimers Dis. 2014; 44(3):1023-34. DOI: 10.3233/JAD-142088. View

van Maurik I, Zwan M, Tijms B, Bouwman F, Teunissen C, Scheltens P . Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project. JAMA Neurol. 2017; 74(12):1481-1491. PMC: 5822193. DOI: 10.1001/jamaneurol.2017.2712. View

ODonovan J, Watson R, Colloby S, Firbank M, Burton E, Barber R . Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?. Int Psychogeriatr. 2012; 25(1):111-9. DOI: 10.1017/S1041610212001214. View

Dubois B, Feldman H, Jacova C, Hampel H, Molinuevo J, Blennow K . Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014; 13(6):614-29. DOI: 10.1016/S1474-4422(14)70090-0. View

Harper L, Barkhof F, Fox N, Schott J . Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry. 2015; 86(11):1225-33. DOI: 10.1136/jnnp-2014-310090. View

ROSEN W, Mohs R, Davis K . A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984; 141(11):1356-64. DOI: 10.1176/ajp.141.11.1356. View

Gonzalez M, Suarez-Sanmartin E, Garcia C, Martinez-Camblor P, Westman E, Simmons A . Manual Planimetry of the Medial Temporal Lobe Versus Automated Volumetry of the Hippocampus in the Diagnosis of Alzheimer's Disease. Cureus. 2016; 8(3):e544. PMC: 4934791. DOI: 10.7759/cureus.544. View

10.

Schneider J, Arvanitakis Z, Leurgans S, Bennett D . The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009; 66(2):200-8. PMC: 2812870. DOI: 10.1002/ana.21706. View

11.

Kapasi A, DeCarli C, Schneider J . Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017; 134(2):171-186. PMC: 5663642. DOI: 10.1007/s00401-017-1717-7. View

12.

Jang J, Park J, Kim S, Park Y, Pyun J, Lim J . A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment. PLoS One. 2018; 13(8):e0201852. PMC: 6101367. DOI: 10.1371/journal.pone.0201852. View

13.

McKhann G, Knopman D, Chertkow H, Hyman B, Jack Jr C, Kawas C . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMC: 3312024. DOI: 10.1016/j.jalz.2011.03.005. View

14.

Victoroff J, Mack W, Grafton S, SCHREIBER S, Chui H . A method to improve interrater reliability of visual inspection of brain MRI scans in dementia. Neurology. 1994; 44(12):2267-76. DOI: 10.1212/wnl.44.12.2267. View

15.

Johnson K, Minoshima S, Bohnen N, Donohoe K, Foster N, Herscovitch P . Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement. 2013; 9(1):e-1-16. PMC: 3733252. DOI: 10.1016/j.jalz.2013.01.002. View

16.

Scheltens P, Erkinjunti T, Leys D, Wahlund L, Inzitari D, del Ser T . White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol. 1998; 39(2):80-9. DOI: 10.1159/000007921. View

17.

Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein H, Vermersch P . Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992; 55(10):967-72. PMC: 1015202. DOI: 10.1136/jnnp.55.10.967. View

18.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

19.

Dubois B, Feldman H, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J . Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734-46. DOI: 10.1016/S1474-4422(07)70178-3. View

20.

Jack Jr C, Bernstein M, Fox N, Thompson P, Alexander G, Harvey D . The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008; 27(4):685-91. PMC: 2544629. DOI: 10.1002/jmri.21049. View